Zacks Investment Research on MSN
Wall Street analysts see a 230.23% upside in Promis Neurosciences (PMN): Can the stock really move this high?
Shares of Promis Neurosciences (PMN) have gained 3.3% over the past four weeks to close the last trading session at $10.75, ...
Promis Neurosciences (PMN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
ProMIS Neurosciences Inc. PMN shares skyrocketed Monday after the company presented preclinical data supporting the potential therapeutic advantage of its lead candidate for Alzheimer's disease (AD), ...
ProMIS Neurosciences Inc. Annual stock financials by MarketWatch. View the latest PMN financial statements, income statements and financial ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results